Accurate Detection of Breast Cancer Metastasis Using a Hybrid Model of Artificial Intelligence Algorithm
Abstract
Background: Breast cancer (BC) is a prevalent disease and a major cause of mortality among women worldwide. A substantial number of BC patients experience metastasis which in turn leads to treatment failure and death. The survival rate has been significantly increased due to more rapid detection and substantial improvements in adjuvant therapies including newer chemotherapeutic and targeted agents, and better radiotherapy techniques.
Methods: In this study, we cross-compared the application of advanced artificial intelligence algorithms such as Logistic Regression, K-Nearest Neighbors, Discrete Cosine Transform, Random Forest Classifier, Support Vector Machines, Multilayer Perceptron, and Ensemble to diagnose BC metastasis. We further combined MLP with genetic algorithm (GA) as a hybrid method of intelligent analysis. The core data we used for comparison belonged to the images of both benign and malignant tumors collected from Wisconsin Breast Cancer dataset from the UCI repository.
Results: The application of several different algorithms to the collection of BC data indicated that these algorithms have comparable accuracy rate in detecting and predicting cancer. However, our hybrid algorithm showed superior accuracy, sensitivity and specificity compared to the individual algorithms. Two methods of comparison (Cross-Validation and Holdout) were applied to this study which produced consistent results.
Conclusion: Our findings indicate that our MLP-GA hybrid algorithm can speed up diagnosis with higher accuracy rate than the individual patterns of algorithm.
Full text article
References
American Cancer Society: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020.pdf.
Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: A Cancer J Clin. 2018; 68(1):7-30.
Breast Cancer Facts & Figures 2017-2018. Atlanta: American Cancer Society, Inc.; 2017.
Meacham C, Morrison S. Tumour heterogeneity and cancer cell plasticity. Nature. 2013. 501:328–337.
National Cancer Institute, 2019, https://www.cancer.gov/types/metastatic-cancer.
Sarıtaş AG, Yalav O, Kekeç Y, Sakman G, et al. Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer. Cukurova Med J. 2019; 44(1):226-231.
Shah R, Rosso K, Nathanson SD. Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol. 2014;5(3):283–298.
Nathanson, KN, Wooster R, & Weber BL. Breast cancer genetics: what we know and what we need. Nature medicine, 2001; 7(5):552.
Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, Pomper MG, Fisher PB. Detecting tumor metastases: the road to therapy starts here. Adv Cancer Res. 2016; 132: 1-44.
Mordente A, Meucci E, Martorana GE, & Silvestrini A. Cancer biomarkers discovery and validation: state of the art, problems and future perspectives. Adv Exp Med Biol. 2015; 867:9-26.
Kumar R, Srivastava R, & Srivastava S. Detection and classification of cancer from microscopic biopsy images using clinically significant and biologically interpretable features. J Med Eng. 2015:14.
Bird B, Romeo M, Laver N, & Diem M. Spectral detection of micro-metastases in lymph node histo-pathology. J Biophotonics. 2009; 2(1-2):37-46.
Spanhol FA, Oliveira LS, Petitjean C, Heutte L. A dataset for breast cancer histopathological image classification. IEEE Trans Biomed Eng. 2016; 63:1455-1462.
Aswathy M, & Jagannath M. Detection of breast cancer on digital histopathology images: Present status and future possibilities. Informatics in Medicine Unlocked. 2017; 8:74-79.
Abdollahi J, Moghaddam BN, & Parvar ME. Improving diabetes diagnosis in smart health using genetic-based Ensemble learning algorithm. Approach to IoT Infrastructure. Future Gen Distrib Systems J. 2019; 1:23-30.
Saritas I. Prediction of breast cancer using artificial neural networks. J Med Syst. 2012; 36: 2901.
Sepandi M, Taghdir M, Rezaianzadeh A, Rahimikazerooni S. Assessing breast cancer risk with an artificial neural network. Asian Pac J Cancer Prev. 2018; 19(4):1017-1019.
Ayer T, Alagoz O, Chhatwal J, Shavlik JW, Kahn CE Jr, Burnside ES. Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration. Cancer. 2010;116(14):3310–3321.
Altman NS. An introduction to kernel and nearest-neighbor nonparametric regression. The Am Stat. 1992; 46 (3): 175–185.
Sarkar M, Leong TY. Application of K-nearest neighbor's algorithm on breast cancer diagnosis problem. Proc AMIA Symp. 2000;759–763.
Zhang H, Wang M. Search for the smallest random forest. Stat Interface. 2009; 2(3):381.
Liu X, Wang X, Su Q, et al. A hybrid classification system for heart disease diagnosis based on the RFRS method. Comput Math Methods Med. 2017; 2017:8272091.
Verma L, Srivastava S, & Negi PC. A Hybrid data mining model to predict coronary artery disease cases using non-invasive clinical data. J Med Syst. 2016, 40, 178.
Kolukisa B, Hacilar H, Goy G, Kus M, Bakir-Gungor B, Aral A, Gungor VC. Evaluation of classification algorithms, linear discriminant analysis and a new hybrid feature selection methodology for the diagnosis of coronary artery disease. IEEE International Conference on Big Data. 2018; 2232-2238.
Mobadersany P, Yousefi S, Amgad M, et al. Predicting cancer outcomes from histology and genomics using convolutional networks. Proc Natl Acad Sci U S A. 2018;115(13):E2970–E2979.
Belciug S, Gorunescu F. A hybrid neural network/genetic algorithm applied to breast cancer detection and recurrence. Expert Systems. 2013; 30(3):243-254.
Authors
Copyright (c) 2020 Archives of Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.